ZVRA

Zevra Therapeutics
$9.71
+$0.18 (+1.94%)Jul 27, 2026
8.4GreatMoatMint rating

MoatMint rates Zevra Therapeutics (ZVRA) 8.4 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 4.1 out of 10.

Key metrics

The numbers that frame ZVRA today
Market cap
$574.01M
P/E (TTM)
4.6
EV / FCF
8.5
Gross margin
86.1%
EV / Sales
3.9
ROIC
67.8%
Div yield
0%
Debt / equity
0.0
52wk Low
$7.16
52wk High
$15.04

ZVRA stock rating

How ZVRA scores on quality, value, growth, momentum and financial health
8.4out of 10
Great overallHealthy business, attractive priceTop 16% of ~5,000 US stocks
QualityNeutral4.1/10
GrowthNeutral4.9/10
MomentumGreat8.3/10
ValueGreat9.5/10
Financial HealthGreat9.5/10

Growth

Revenue and earnings trend for ZVRA
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about ZVRA
Is Zevra Therapeutics a good buy?
Hold. Zevra Therapeutics has excellent momentum, but weak quality makes the setup mixed. Growth looks mixed. The support signal is useful, but not decisive. We think Zevra Therapeutics is selling at a low price.
What is the market capitalization of ZVRA?
Zevra Therapeutics's market capitalization is $574.01M.
What is the P/E ratio for ZVRA stock?
Zevra Therapeutics's current P/E ratio is 4.6.
What is the 52-week high for ZVRA stock?
The 52-week high for Zevra Therapeutics is $15.04. The current close of $9.71 is 35.4% below that high.
What is the 52-week low for ZVRA stock?
The 52-week low for Zevra Therapeutics is $7.16. The current close of $9.71 is 35.6% above that low.
Does ZVRA stock pay dividends?
Zevra Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ZVRA?
Zevra Therapeutics's Debt / Equity ratio is 0.01.